Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE Study.

@article{Gilmore2014AntiemeticGC,
  title={Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE Study.},
  author={James W. Gilmore and Nancy Walker Peacock and Anna Gu and Stephen A Szabo and Melissa Rammage and Joyce Sharpe and Sally T Haislip and Toni S Perry and Tim Lee Boozan and Katherine Meador and Xiting Cao and Thomas Burke},
  journal={Journal of oncology practice},
  year={2014},
  volume={10 1},
  pages={68-74}
}
PURPOSE Consensus guidelines for preventing chemotherapy-induced nausea and vomiting (CINV) are variably implemented in practice. The purpose of this study was to evaluate the impact of guideline-consistent/guideline-inconsistent CINV prophylaxis (GCCP/GICP) on the incidence of no CINV after cycle 1 of highly or moderately emetogenic chemotherapy (HEC or MEC). PATIENTS AND METHODS This prospective observational study enrolled chemotherapy-naive adult outpatients who received single-day HEC or… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS